Exelon Corporation (NASDAQ:EXC - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $45.56 and traded as high as $46.03. Exelon shares last traded at $45.91, with a volume of 10,426,979 shares.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on EXC shares. BMO Capital Markets dropped their price objective on shares of Exelon from $47.00 to $45.00 and set a "market perform" rating on the stock in a report on Thursday, October 22nd. Truist Financial reduced their target price on shares of Exelon from $48.00 to $46.00 and set a "hold" rating for the company in a research note on Friday, October 16th. HSBC initiated coverage on shares of Exelon in a research report on Thursday, October 22nd. They issued a "hold" rating and a $44.00 target price for the company. Argus dropped their price target on shares of Exelon from $52.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, September 22nd. Finally, JPMorgan Chase & Co. dropped their price target on shares of Exelon from $47.00 to $46.00 and set a "neutral" rating on the stock in a research note on Monday, October 19th. Six equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $48.58.
Get Our Latest Stock Analysis on Exelon
Exelon Trading Up 2.5%
The business has a fifty day moving average of $42.83 and a 200-day moving average of $45.56. The stock has a market capitalization of $47.39 billion, a price-to-earnings ratio of 16.82, a price-to-earnings-growth ratio of 2.45 and a beta of 0.30. The company has a debt-to-equity ratio of 1.71, a current ratio of 1.09 and a quick ratio of 0.99.
Exelon (NASDAQ:EXC - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by ($0.01). The company had revenue of $5.97 billion for the quarter, compared to analyst estimates of $5.44 billion. Exelon had a return on equity of 9.81% and a net margin of 10.99%. The firm's revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the firm earned $0.39 earnings per share. On average, equities analysts anticipate that Exelon Corporation will post 2.86 earnings per share for the current fiscal year.
Institutional Trading of Exelon
Institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Exelon during the 2nd quarter worth about $5,583,709,000. Lazard Asset Management LLC boosted its position in Exelon by 6.4% during the first quarter. Lazard Asset Management LLC now owns 24,620,304 shares of the company's stock worth $1,206,887,000 after purchasing an additional 1,490,251 shares during the period. GQG Partners LLC bought a new stake in Exelon during the second quarter worth approximately $922,917,000. Legal & General Group Plc acquired a new position in Exelon during the second quarter valued at approximately $602,760,000. Finally, Bank of New York Mellon Corp acquired a new position in Exelon during the second quarter valued at approximately $580,842,000. Institutional investors and hedge funds own 80.92% of the company's stock.
Exelon Company Profile
(
Get Free Report)
Exelon Corporation NASDAQ: EXC is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.
Exelon's utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.